M. Diez et al., Influence of tumor localization on the prognostic value of p53 protein in colorectal adenocarcinomas, ANTICANC R, 20(5C), 2000, pp. 3907-3912
Background: The prevalence of genetic alterations is different in primary c
arcinomas from the proximal colon when compared with carcinomas from the di
stal colorectum. The objective of this work was to explore the existence of
possible differences in the informative weight of the risk of tumor recurr
ence provided by p53 immunostaining depending on the localization of the ne
oplasm. Patients and Methods: Nuclear immunohistochemical expression of p53
protein was determined in formalin-fixed paraffin-embedded archival tumor
tissue samples from 190 primary colorectal adenocarcinomas. The relative pr
ognostic importance on the risk of recurrence of each variable was assessed
in a Cox's proportional hazard regression analysis. Multiplicative interac
tion terms between p53 and tumor sire were included in the multivariate mod
els in order to test their joint effect on survival. Results: One hundred a
nd one patients (53.1%) manifested nuclear accumulation of the protein. P53
overexpression was more frequent in distal than in proximal tumors (58.5%
ve s 41.7%) (p=0.03). Disease-free survival was lower in p53-positive cases
(75% versus 38%) (p=0.006), but significance of the association varied acc
ording to the localization of the tumor (p=0.004 in proximal carcinomas and
p=0.049 in distal carcinomas). Multivariate analysis identified p53 positi
vity and distal tumor localization as the factors significantly associated
with a high risk of recurrence Interaction between p53 expression and local
ization was present. P53 exhibited different prognostic value in distal and
proximal colon. While adjusted hazard ratio for positive p53 was 1.99 in d
istal cancers, it was 8.04 for proximal tumors. Conclusion: The prognostic
with value of tumor recurrence associated overexpression of p53 protein is
influenced by the location of the tumor The negative predictive weight is s
ignificantly higher in proximal than in distal cancers.